These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12546968)

  • 41. Drug discovery today.
    Schwardt O; Kolb H; Ernst B
    Curr Top Med Chem; 2003; 3(1):1-9. PubMed ID: 12570684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pursuing the leadlikeness concept in pharmaceutical research.
    Hann MM; Oprea TI
    Curr Opin Chem Biol; 2004 Jun; 8(3):255-63. PubMed ID: 15183323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computational Chemistry in the Pharmaceutical Industry: From Childhood to Adolescence.
    Hillisch A; Heinrich N; Wild H
    ChemMedChem; 2015 Dec; 10(12):1958-62. PubMed ID: 26358802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Straightforward recursive partitioning model for discarding insoluble compounds in the drug discovery process.
    Lamanna C; Bellini M; Padova A; Westerberg G; Maccari L
    J Med Chem; 2008 May; 51(10):2891-7. PubMed ID: 18419111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolution of the physicochemical properties of marketed drugs: can history foretell the future?
    Faller B; Ottaviani G; Ertl P; Berellini G; Collis A
    Drug Discov Today; 2011 Nov; 16(21-22):976-84. PubMed ID: 21782967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The properties of known drugs. 1. Molecular frameworks.
    Bemis GW; Murcko MA
    J Med Chem; 1996 Jul; 39(15):2887-93. PubMed ID: 8709122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combinatorial chemistry, automation and molecular diversity: new trends in the pharmaceutical industry.
    Van Hijfte L; Marciniak G; Froloff N
    J Chromatogr B Biomed Sci Appl; 1999 Apr; 725(1):3-15. PubMed ID: 10226874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Focus on success: using a probabilistic approach to achieve an optimal balance of compound properties in drug discovery.
    Segall MD; Beresford AP; Gola JM; Hawksley D; Tarbit MH
    Expert Opin Drug Metab Toxicol; 2006 Apr; 2(2):325-37. PubMed ID: 16866617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DrugViz: a Cytoscape plugin for visualizing and analyzing small molecule drugs in biological networks.
    Xiong B; Liu K; Wu J; Burk DL; Jiang H; Shen J
    Bioinformatics; 2008 Sep; 24(18):2117-8. PubMed ID: 18658180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toward designing drug-like libraries: a novel computational approach for prediction of drug feasibility of compounds.
    Wang J; Ramnarayan K
    J Comb Chem; 1999; 1(6):524-33. PubMed ID: 10748729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A scoring scheme for discriminating between drugs and nondrugs.
    Sadowski J; Kubinyi H
    J Med Chem; 1998 Aug; 41(18):3325-9. PubMed ID: 9719584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Automating drug discovery.
    Schneider G
    Nat Rev Drug Discov; 2018 Feb; 17(2):97-113. PubMed ID: 29242609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficient calculation of compound similarity based on maximum common subgraphs and its application to prediction of gene transcript levels.
    Berlo RJ; Winterbach W; Groot MJ; Bender A; Verheijen PJ; Reinders MJ; Ridder DD
    Int J Bioinform Res Appl; 2013; 9(4):407-32. PubMed ID: 23797997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and selection of "privileged fragments" suitable for primary screening.
    Gianti E; Sartori L
    J Chem Inf Model; 2008 Nov; 48(11):2129-39. PubMed ID: 18991373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery pharmaceutics--challenges and opportunities.
    Chen XQ; Antman MD; Gesenberg C; Gudmundsson OS
    AAPS J; 2006 Jun; 8(2):E402-8. PubMed ID: 16796392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knowledge-based chemoinformatic approaches to drug discovery.
    Ghose AK; Herbertz T; Salvino JM; Mallamo JP
    Drug Discov Today; 2006 Dec; 11(23-24):1107-14. PubMed ID: 17129830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chemical drug development].
    Castro B
    Ann Pharm Fr; 2002 May; 60(3):147-9. PubMed ID: 12050592
    [No Abstract]   [Full Text] [Related]  

  • 58. Selection criteria for drug-like compounds.
    Muegge I
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Applying technologies towards safe and effective medicines.
    Roses AD
    Biotechniques; 2005 Oct; 39(4):563-4. PubMed ID: 16235568
    [No Abstract]   [Full Text] [Related]  

  • 60. EDULISS: a small-molecule database with data-mining and pharmacophore searching capabilities.
    Hsin KY; Morgan HP; Shave SR; Hinton AC; Taylor P; Walkinshaw MD
    Nucleic Acids Res; 2011 Jan; 39(Database issue):D1042-8. PubMed ID: 21051336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.